Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study
Open Access
- 16 July 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 5 (2) , 136-144
Abstract
Randomized clinical trials investigating a possible outcome effect of remote monitoring in patients with implantable defibrillators have shown conflicting results. This study analyses the information flow and workflow details from the IN-TIME study and discusses whether differences of message content, information speed and completeness, and workflow may contribute to the heterogeneous results. IN-TIME randomized 664 patients with an implantable cardioverter/defibrillator indication to daily remote monitoring vs. control. After 12 months, a composite clinical score and all-cause mortality were improved in the remote monitoring arm. Messages were received on 83.1% of out-of-hospital days. Daily transmissions were interrupted 2.3 times per patient-year for more than 3 days. During 1 year, absolute transmission success declined by 3.3%. Information on medical events was available after 1 day (3 days) in 83.1% (94.3%) of the cases. On all working days, a central monitoring unit informed investigators of protocol defined events. Investigators contacted patients with a median delay of 1 day and arranged follow-ups, the majority of which took place within 1 week of the event being available. Only limited data on the information flow and workflow have been published from other studies which failed to improve outcome. However, a comparison of those data to IN-TIME suggest that the ability to see a patient early after clinical events may be inferior to the set-up in IN-TIME. These differences may be responsible for the heterogeneity found in clinical effectiveness of remote monitoring concepts.Keywords
Funding Information
- Biotronik SE & Co
This publication has 25 references indexed in Scilit:
- HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devicesHeart Rhythm, 2015
- Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation “IEGM Online” systemEP Europace, 2015
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialThe Lancet, 2014
- Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trialEuropean Heart Journal, 2013
- Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable DefibrillatorsCirculation, 2012
- The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) TrialJACC, 2011
- Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-UpCirculation, 2010
- Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-UpCirculation, 2010
- Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillatorsEP Europace, 2009
- HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical ConsiderationsDeveloped in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart AssociationEP Europace, 2008